Norman Wolmark, M.D.

Current professional and academic appointments (Include starting date):

1991 - Present:		Senior Lecturer in Biomedical Engineering, Carnegie Mellon University, Pittsburgh, PA
1994 - Present:		Center Director, Allegheny Singer Research Institute, Human Oncology Research Center, Pittsburgh, PA
1994 - Present:		Chairman & Principal Investigator, National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA
1995 - Present:		Director, Allegheny General Hospital, Breast Center, Pittsburgh, PA
2001 - Present:		Professor and Chairman, Department of Human Oncology, Drexel University College of Medicine
2001 - Present:		Director, West Penn Allegheny Health System Oncology, Pittsburgh, PA

Undergraduate medical education (including dates and degrees):

1966 - 1970:

M.D., McGill University, Montreal, Canada

Postgraduate medical education (including dates of internships, residencies, fellowships, etc.):

1970 - 1971:		Intern, McGill Unviersity, Montreal, Canada
1971 - 1973:		General Surgery Resident, McGill University, Montreal, Canada
1973 - 1974:		Research Fellow, University of Pittsburgh, Pittsburgh, PA
1974 - 1975:		Surgery Resident, University of Pittsburgh, Pittsburgh, PA
1975 - 1976:		Senior Surgery Resident, University of Pittsburgh, Pittsburgh, PA

BASIC RESEARCH

Project:		Primary Breast Cancer Therapy Group, NSABP Headquarters, Co-Investigator and Executive Medical Director 1970 - 1987
Funding source:		NIH - U10-CA-12027
Project:		Primary Breast Therapy Group NSABP, NSABP Headquarter, Co-Investigator and Executive Medical director 1970 - 1987.
Funding source:		NIH-U10-CA-34211
Project:		Therapy of Patients with Colo-Rectal Cancer, NSABP Headquarters, Co-Investigator and Executive Medical Director 1977 - 1987.
Funding source:		NIH-U10-CA-34212
Project:		Surgical Removal of the Primary Tumor, Immunity and Metastases, Co-Investigator 1982 - 1985.
Funding source:		NIH-CA-14972
Project:		Primary Breast Cancer Therapy Group, NSABP Institutional Grant, Co-Investigator 1970 -1987.
Funding source:		NIH-CA-12028
Project:		Therapy Effects on Tumor Kinetics and Immune Parameters, Co-Investigator 1979 - 1980.
Funding source:		NIH-CA-26004
Project:		Surgical Management of the Regional Lymph node in Cancer, Co-Investigator 1974 - 1980.
Funding source:		NIH-CA-12102
Project:		Murine Studies in Surgical Adjuvant Adoptive Immunotherapy - ACS, Principal Investigator 1985 - 1987.
Funding source:		IN-58V
Project:		Murine Studies in Surgical Adjuvant Adoptive Immunotherapy, Principal Investigator 1985 - 1988.
Funding source:		NIH R01-CA37113-01A1
Project:		Primary Breast Cancer Therapy Group, NSABP Headquarters, Co-Investigator, 1987 - 1992.
Funding source:		NIH U10-CA 12027-16
Project:		Primary Breast Cancer Therapy Group, NSABP Headquarters, Co-Investigator, 1992 - 1994.
Funding source:		NIH U10-CA 12027-21
Project:		Community Clinical Oncology Program, CCOP Research Grant, Principal Investigator, 1995 - 1996.
Funding source:		NIH U10-CA37377-11
Project:		Primary Breast Cancer Therapy Group, NSABP Operations Center, Principal Investigator, 1995 - 1996.
Funding source:		NIH U10-CA 12027-24-25
Project:		National surgical Adjuvant Breast and Bowel Project Treatment Grant (AUHS), Principal Investigator 1996 - 2000, Supplement: Tissue Bank Correlative Studies.
Funding source:		NIH U10-CA 12027-26-29
Project:		Community Clinical Oncology Program, CCOP Research Grant (AUHS), principal Investigator, 1996 - 2000.
Funding source:		NIH U10-CA 37377-12-15
Project:		Allegheny Community Cancer Network (AUHS), Principal Investigator, 1996 - 2000.
Funding source:		NIH-CA 71240-00-04
Project:		National Surgical Adjuvant Breast and Bowel Project, Principal Investigator (04/01/00 - six year renewal)
Funding source:		NIH-2-U1-CA-12027-30

Recent publications and presentations:

Peer-reviewed publications (i.e., journal articles)

Fisher ER, Colangelo L, Wieand S, Fisher B, Wolmark N. Lack of influence of cytokeratin-positive mini micrometastases in "Negative Node" patients with colorectal cancer: findings from the national surgical adjuvant breast and bowel projects protocols R-01 and C-01. Dis Colon Rectum. 2003 Aug;46(8):1021-5.

Tan-Chiu E, Wang J, Costantino JP, Paik S, Butch C, Wickerham DL, Fisher B, Wolmark N. Effects of tamoxifen on benign breast disease in women at high risk for breast cancer. J Natl Cancer Inst. 2003 Feb 19;95(4):302-7.

Dignam JJ, Ye Y, Colangelo L, Smith R, Mamounas EP, Wieand HS, Wolmark N. Prognosis after rectal cancer in blacks and whites participating in adjuvant therapy randomized trials.J Clin Oncol. 2003 Feb 1;21(3):413-20.

Allegra CJ, Paik S, Colangelo LH, Parr AL, Kirsch I, Kim G, Klein P, Johnston PG, Wolmark N, Wieand HS. Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes' B and C colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project collaborative study. J Clin Oncol. 2003 Jan 15;21(2):241-50.

Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, Wolmark N. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002 Oct 17;347(16):1233-41.

Fisher B, Bryant J, Dignam JJ, Wickerham DL, Mamounas EP, Fisher ER, Margolese RG, Nesbitt L, Paik S. Pisansky TM, Wolmark N, National Surgical Adjuvant Breast and Bowel Project. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol. 2002 Oct 15;20(20):4141-9.

Other publications (i.e., non-peer-reviewed articles, book chapters, etc.)

Wolmark N, Rockette H, Fisher B, Wickerham DL, Redmond C. Fisher ER, Jones J, Mamounas E, Ore L, Petrelli N, Spurr C. Dimitorv N, romond E. Sutherland C, Kardinal C, DeFusco P, Jochisem P. The benefit of leucovorin-modulated fluorouracil as post-operative adjuvant therapy for primary colon cancer: Results from National Surgical Adjuvant Breast and Bowel Project Protocol C-03. Jrnl Clin Oncol Classic Papers and Comments, December 1998.

Wolmark N, Rockette H, Wickerham DL, Fisher , Redmond C, Fisher ER, Potvin M, Davies R, Jones J, Robidoux A, Wexler M, Gordon P, Cruz A, Horsley S, Nims T, Thirwell M, Phillips W, Prager D, Stern H, Lerner H, Frazier. Adjuvant therapy of dukes' A, B and C adenocarcinoma of the colon with portal-vein fluorouracil hepatic infusion: Preliminary results of National Surgical Adjuvant Breast and Bowel Project Protocol C-02. Jrnl Clin Oncol Classic Papers and Comments, December 1998.

National/regional presentations

14th International Congress on Anti-Cancer Treatment (ICACT), Paris France, Invited Speaker, "Local treatments in breast cancer; Breast cancer chemo-prevention. February 2003.

European Society of Medical Oncology (ESMO) Meeting, Nice, France, Invited Speaker, "Turning-Point in Colorectal Cancer Management", October 2002.

The 213th Lilly Lecture, Indianapolis, IN, Invited Speaker, "Clinical Research in Breast Cancer and the Role of NSABP: Two Tales of One City, July 2002.

American Society of Clinical Oncology 2002 Annual Meeting, Invited Speaker, "NSABP Experience", May 2002.

International Society of University Colon and Rectal Surgeons, Invited Speaker, Osaka, Japan, April 2002.

Exoxatine International Meeting, Budapest, Hungary, Chairman, "Perspectives in new Elxatin combinations in CRC Eloxatin beyond colorectal cancer, an extensive clinical development", March 2002.

Aventis/Taxotere Meeting, Maui, HI, Invited Lecturer, "Overview of Taxotere and breast cancer in the surgical setting", March 2002.

NMCR Annual Meeting, Las Vegas, NV, Invited Speaker, "Breast cancer diagnostic and therapeutic controversies", February 2002.

12th International Congress on Anti Cancer Treatment, Paris, France, Invited Lecturer, "Taxotere in breast cancer" and "Breast cancer diagnostic and therapeutic controversies", February 2002.

San Antonio Breast Review Meeting, Pittsburgh, PA, Invited Lecturer, "Preliminary results for NSABP Protocol B-27", January 2002.

Other presentations

"Contribution of the NSABP Clinical Trials to the Management of Breast Cancer", Surgical Grand Rounds, Allegheny General Hospital, Pittsburgh, PA, October 8, 2002.

> Back to Combined Faculty Listing